ugc_banner

UK approves single shot Johnson & Johnson coronavirus vaccine

WION Web Team
New DelhiUpdated: May 28, 2021, 06:06 PM IST

Johnson & Johnson coronavirus vaccine (file photo). Photograph:(Reuters)

Story highlights

Johnson & Johnson Covid vaccine was found to be 72 per cent effective in preventing moderate to severe coronavirus infection, according to a US trial

UK on Friday approved the single-shot Covid vaccine developed by Johnson & Johnson, as per the announcement by the Medicines and Healthcare products Regulatory Agency (MHRA). 

"This is a further boost to the UK's hugely successful vaccination programme, which has already saved over 13,000 lives, and means that we now have four safe and effective vaccines approved to help protect people from this awful virus," said Health Secretary Matt Hancock.

He added that the government hoped that the single-dose jab "will play an important role in the months to come". Britain has ordered 20 million doses of the vaccine.

Johnson & Johnson Covid vaccine was found to be 72 per cent effective in preventing moderate to severe coronavirus infection, according to a US trial.

Britain has administered more than 62 million shots so far, mainly using the Pfizer and AstraZeneca vaccines. It has also approved the use of the Moderna vaccine.

After months of falling cases, infections have started to rise again due to the emergence of the Indian variant, which has put in doubt plans for a full reopening of the country on June 21.

(With inputs from agencies)